Skip to main content
. 2021 May 23;43(1):187–196. doi: 10.3390/cimb43010016

Figure 5.

Figure 5

OSCC stem cells were treated with the different concentrations of allicin and acquired on flow cytometer to examine the expression of cancer stem cell markers CD133 and CD44. n.s. not significant, ** p < 0.05, *** p < 0.01.